Personalis, Inc.
PSNL- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001527753
In the last 90 days, Personalis, Inc. insiders filed 0 open-market purchases and 6 sales; 158 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; ARK Invest is the only superinvestor holding it.
Q1 2022 vs. Q4 2021
How the institutions holding Personalis, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 108 | 125 | +17 |
| Shares | 32.2M | 32.5M | +321.3K (+1.0%) |
| Value | $456.2M | $265.3M | −$190.9M (−41.8%) |
New holders (27)
Institutions that held Personalis, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (10)
Institutions that held Personalis, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Candriam Luxembourg S.C.A. | 352,500 | $5.03M |
| Norges Bank | 99,800 | $1.42M |
| Jane Street Group, LLC | 24,305 | $347.0K |
| Skandinaviska Enskilda Banken AB (publ) | 22,821 | $325.0K |
| Aristides Capital LLC | 21,260 | $303.0K |
| PDT Partners, LLC | 18,463 | $263.0K |
| IndexIQ Advisors LLC | 17,160 | $245.0K |
| Migdal Insurance & Financial Holdings Ltd. | 1,225 | $17.0K |
| Spire Wealth Management | 350 | $5.00K |
| TCI Wealth Advisors, Inc. | 309 | $4.00K |